Confidentiality
Define what constitutes confidential information, permitted disclosures (e.g., to employees under a need-to-know basis), and the duration of nondisclosure obligations to protect trade secrets during and after the evaluation period.
An Evaluation Agreement reduces legal and operational risk by restricting use of confidential materials, clarifying IP rights for feedback, and establishing remedies for misuse. It sets clear timelines and obligations so both parties understand their responsibilities during a limited trial.
Common parties include software vendors offering trials, procurement or product teams running pilots, legal counsel reviewing IP allocation, and prospective customers evaluating fit.
These groups use the agreement to balance necessary access for testing with protections for trade secrets, data handling, and defined exit obligations if the trial ends without a license.
The provider’s authorized technical or executive representative (commonly the CTO or VP of Product) signs to permit evaluation access, confirm scope of permitted use, and accept responsibilities for hosting, support, and any demo data used during the trial.
The recipient’s procurement or legal lead signs to accept the evaluation terms, confirm internal data protection measures, and agree to return or destroy materials at the trial’s end; signature binds the organization to confidentiality and permitted-use clauses.
Define what constitutes confidential information, permitted disclosures (e.g., to employees under a need-to-know basis), and the duration of nondisclosure obligations to protect trade secrets during and after the evaluation period.
Specify exactly what the recipient may do with the product or materials during the trial (testing, internal demonstration) and prohibit prohibited actions such as reverse engineering or production deployment.
Clarify ownership of preexisting IP, feedback, and improvements; include whether feedback grants a license and whether any assignment of rights is required for bug fixes or enhancements.
Set procedures and deadlines for return or certified destruction of materials, including any required confirmations and the format in which data must be returned or erased.
Include disclaimers of warranties, caps on damages, and indemnities where appropriate to allocate risk between the provider and recipient for trial-related losses or claims.
Establish grounds for immediate termination, injunctive relief for confidentiality breaches, and remedies including return of materials and recovery of costs or damages.
The date the agreement takes effect and starts the evaluation period.
The final day of permitted testing and access unless extended in writing.
Deadline for either party to request a trial extension, typically a set number of days before end.
Date by which materials must be returned or destroyed after termination.
Specify which obligations (e.g., confidentiality, IP) survive termination and for how long.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |